How to deliver echocardiography services during the COVID-19 pandemic
The novel coronavirus (SARS-CoV-2) is highly contagious and poses potential risk to healthcare professionals, which has affected healthcare services around the world.
How has COVID-19 impacted echocardiography delivery?
Since echocardiography is a patient-facing investigation that involves close patient contact over an extended period, care must be taken when considering its delivery.
To break the chain of infection, higher thresholds to perform bedside echocardiography have been implemented. In addition, there’s more focus on performing targeted studies to limit time spent at the bedside (and therefore reduce subsequent exposure of both the patient and health care workers to the virus).
There are three key principles to remember when choosing the format and level of your ECHO imaging during the COVID-19 pandemic:
- The risk of infection (or the patient’s COVID-19 status)
- The indications for echocardiography (and the correct protocol to be used)
- The appropriate level of imaging
Figure 1. Three key principles for echocardiography delivery during the COVID-19 pandemic include assessing the risk of infection, clarifying the indications for echocardiography, and delivering the appropriate level of imaging.
During the COVID-19 pandemic, all routine echocardiography studies have been widely postponed with a focus on in-patient echocardiograms for patients who require urgent cardiac assessment.
In all cases, transthoracic echocardiography (TTE) is preferred since transesophageal echocardiography (TEE) produces aerosols, and therefore presents a higher risk of spreading infection.
That’s it for now. If you want to improve your understanding of key concepts in medicine, and improve your clinical skills, make sure to register for a free trial account, which will give you access to free videos and downloads. We’ll help you make the right decisions for yourself and your patients.
- Chamsi-Pasha, MA, Sengupta, PP, and Zoghbi, WA. 2017. Handheld echocardiography: Current state and future perspectives. Circulation. 136: 2178–2188. PMID: 29180495
- Clerkin, KJ, Fried, JA, Raikhelkar, J, et al. 2020. COVID-19 and cardiovascular disease. Circulation. 141: 1648–1655. PMID: 32200663
- Doyen, D, Moceri, P, Ducreux, D, et al. 2020. Myocarditis in a patient with COVID-19: A cause of raised troponin and ECG changes. Lancet. 395: 1516. PMID: 32334650
- Drake, DH, De Bonis, M, Covella, M, et al. 2020. Echocardiography in pandemic: Front-line perspective, expanding role of ultrasound and ethics of resource allocation. J Am Soc Echocardiogr. 33: 683–689. PMID: 32503707
- Fukuhara, S, Rosati, CM, and El-Dalati, S. 2020. Acute type A aortic dissection during the COVID-19 outbreak. Ann Thorac Surg. 110: e405–e407. PMID: 32333849
- Haji, K, Wong, C, Neil, C, et al. 2019. Handheld ultrasound to reduce requests for inappropriate echocardiogram (HURRIE). Echo Res Pract. 6: 91–96. PMID: 31516721
- Hua, A, O’Gallagher, K, Sado, D, et al. 2020. Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19. Eur Heart J. 41: 2130. PMID: 32227076
- Johri, AM, Galen, B, Kirkpatrick, JN, et al. 2020. ASE statement on point-of-care ultrasound during the 2019 novel coronavirus pandemic. J Am Soc Echocardiogr. 33: 670–673. PMID: 32503704
- Meyer, P, Degrauwe, S, Van Delden, C, et al. 2020. Typical takotsubo syndrome triggered by SARS-CoV-2 infection. Eur Heart J. 41: 1860. PMID: 32285915
- Neskovic, AN, Hagendorff, A, Lancellotti, P, et al. 2013. Emergency echocardiography: The European association of cardiovascular imaging recommendations. Eur Heart J Cardiovasc Imaging. 14: 1–11. PMID: 23239795
- Nguyen, VTQ, Ho, JE, Ho, CY, et al. 2008. Handheld echocardiography offers rapid assessment of clinical volume status. Am Heart J. 156: 537–542. PMID: 18760138
- Poissy, J, Goutay, J, Caplan, M, et al. 2020. Pulmonary embolism in patients with COVID-19: Awareness of an increased prevalence. Circulation. 142: 184–186. PMID: 32330083
- Shi, S, Qin, M, Shen, B, et al. 2020. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 5: 802–810. PMID: 32211816
- The American Society of Echocardiography. ASE statement on protection of patients and echocardiography service providers during the 2019 novel coronavirus outbreak. 2020. ASEcho.org. https://www.asecho.org
- The American Society of Echocardiography. Cleaning recommendations from ultrasound manufacturers. 2020. ASEcho.org. https://www.asecho.org
- The Department of Health and Social Care (DHSC), Public Health Wales (PHW), Public Health Agency (PHA) Northern Ireland, Health Protection Scotland (HPS) and Public Health England. COVID-19: Guidance for infection prevention and control in healthcare settings. Version 1.0. 2020. rcslt.org. https://www.rcslt.org
- Zeng, JH, Liu, YX, Yuan, J, et al. 2020. First case of COVID-19 complicated with fulminant myocarditis: A case report and insights. Infection. 48: 773–777. PMID: 32277408